Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aravind S Ravi Kumar

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
Could FAP-Targeted Molecular Imaging Replace <sup>18</sup>F-FDG for Standard-of-Care Oncologic PET?Raghava Kashyap, Aravind S Ravi Kumar
European Urology Focus|June 19, 2026
Prostate Cancer Working Group 4 RecapAravind S Ravi Kumar, Aaron R Hansen
Clinical Nuclear Medicine|February 3, 2011
Palpation thyroiditis seen on F-18 FDG PET/CTJohn K Blazak, Aravind S Ravi Kumar
Clinical Nuclear Medicine|March 28, 2013
Classical skeletal injuries shown on 18F-FDG PET/CT following successful cardiopulmonary resuscitationYu-Ting Huang, Aravind S Ravi Kumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
Unraveling the Impact of <sup>177</sup>Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from CorrelationAravind S Ravi Kumar, Michael S Hofman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Mechanistic Insights for Optimizing PSMA Radioligand TherapyAravind S Ravi Kumar, Michael S Hofman
Clinical Nuclear Medicine|December 21, 2006
Incidental finding of thyroid uptake of tc-99m tetrofosmin on a myocardial perfusion scanShanthi Kannan, Aravind S Ravi Kumar, Matthew Griffiths
Nuclear Medicine Communications|January 21, 2012
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinomaYi-Tung Tom Huang, Aravind S Ravi Kumar
Clinical Nuclear Medicine|April 8, 2016
Focal Inflammatory Myositis on 18F-FDG PET/CTOlivia Bennett, Aravind S Ravi Kumar, Julie Agnew
Nuclear Medicine Communications|October 24, 2014
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancersYu-Ting Huang, Aravind S Ravi Kumar, Sandeep Bhuta
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
Could FAP-Targeted Molecular Imaging Replace <sup>18</sup>F-FDG for Standard-of-Care Oncologic PET?Raghava Kashyap, Aravind S Ravi Kumar
European Urology Focus|June 19, 2026
Prostate Cancer Working Group 4 RecapAravind S Ravi Kumar, Aaron R Hansen
Clinical Nuclear Medicine|February 3, 2011
Palpation thyroiditis seen on F-18 FDG PET/CTJohn K Blazak, Aravind S Ravi Kumar
Clinical Nuclear Medicine|March 28, 2013
Classical skeletal injuries shown on 18F-FDG PET/CT following successful cardiopulmonary resuscitationYu-Ting Huang, Aravind S Ravi Kumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
Unraveling the Impact of <sup>177</sup>Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from CorrelationAravind S Ravi Kumar, Michael S Hofman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Mechanistic Insights for Optimizing PSMA Radioligand TherapyAravind S Ravi Kumar, Michael S Hofman
Clinical Nuclear Medicine|December 21, 2006
Incidental finding of thyroid uptake of tc-99m tetrofosmin on a myocardial perfusion scanShanthi Kannan, Aravind S Ravi Kumar, Matthew Griffiths
Nuclear Medicine Communications|January 21, 2012
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinomaYi-Tung Tom Huang, Aravind S Ravi Kumar
Clinical Nuclear Medicine|April 8, 2016
Focal Inflammatory Myositis on 18F-FDG PET/CTOlivia Bennett, Aravind S Ravi Kumar, Julie Agnew
Nuclear Medicine Communications|October 24, 2014
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancersYu-Ting Huang, Aravind S Ravi Kumar, Sandeep Bhuta
Pageof 5